latest articles

Commercial Real Estate Pros. More Optimistic

A recent survey of 50 local real estate professionals showed signs of optimism about the commercial real estate market during the next two years, despite an anticipated increase in land prices and building materials.

MN Cos. Affected as J&J Exits Stent Market

As Johnson & Johnson prepares to stop manufacturing drug-coated stents, competitors like Medtronic and Boston Scientific could see a boost in sales. Surmodics, however, a supplier to Johnson & Johnson, said that it is "disappointed" with the news.

MN Med-Tech Cos. Dispute New Heart Device Study

Roughly 40 percent of patients implanted with cardiac resynchronization therapy devices may not reap benefits from the expensive treatment, according to a new study. But med-tech giants Medtronic and St. Jude disagree, stating that current guidelines for using the devices were established through credible clinical trials.